EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinicopathological and prognostic analysis of anaplastic lymphoma kinase-rearranged non-small cell lung cancer

Hidenao Kayawake, Katsutaka Mineura, Ichiro Sakanoue, Ryota Sumitomo, Shigeto Nishikawa, Satona Tanaka, Kentaro Tsuji, Daisuke Nakajima, Toshi Menju, Toyofumi Fengshi Chen-Yoshikawa

General Thoracic and Cardiovascular Surgery · 27.10.2026

DOI: 10.1007/s11748-026-02424-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift General Thoracic and Cardiovascular Surgery, online erschienen am 27.10.2026. Verfasst von Hidenao Kayawake und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Kyoto University Hospital, 54 Shogoin-Kawahara-cho, Sakyo-ku, 606-8507, Kyoto, Japan. kayawake.hidenao.g6@f.mail.nago…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer (NSCLC) accounts for 2‒7% of NSCLC cases and is prone to lymph node and distant metastases. We analyzed the clinicopathologic features and prognosis of patients with ALK-rearranged NSCLC who underwent surgery.

Methods

This study included 30 patients who underwent surgery for ALK-rearranged NSCLC between January 2017 and September 2025, representing ~ 1.6% of all primary lung cancer surgeries performed during the same period.

Results

The median age was 68 years, 19 patients were male, and 14 (46.7%) had a smoking history. Clinical stages were I ( n = 22), II ( n = 1), and III ( n = 7). Lobectomy was the most common surgical procedure ( n = 19), followed by partial resection ( n = 6) and segmentectomy ( n = 5). Complete resection was achieved in 26 (86.7%) patients. Pathological upstaging occurred in 11 (36.7%) patients. Postoperative recurrence occurred in 10 patients after complete resection, with a median recurrence-free interval of 554.5 days; eight patients received an ALK tyrosine kinase inhibitor (ALK-TKI). Among five patients with clinical stage III NSCLC receiving induction chemoradiotherapy, four underwent complete resection, but all experienced postoperative recurrence. The 5-year overall survival rate of the entire cohort was 89.5% (95% confidence interval [CI] 64.1‒97.3%), while the 5-year recurrence-free survival rate after complete resection was 51.2% (95% CI 27.4‒70.7%).

Conclusions

Given the high recurrence rates associated with conventional perioperative treatment and occasional unexpected upstaging, a treatment strategy centered on surgical resection and ALK-TKIs may be important for ALK-rearranged NSCLC.

Schlagwörter

Stichwörter der Autor:innen

ALKAnaplastic lymphoma kinase-rearranged non-small-cell lung cancerPrognosisSurgical outcome

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Kyoto University Hospital, 54 Shogoin-Kawahara-cho, Sakyo-ku, 606-8507, Kyoto, Japan. kayawake.hidenao.g6@f.mail.nagoya-u.ac.jp.
  • Department of Thoracic Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, 466-8550, Nagoya, Japan. kayawake.hidenao.g6@f.mail.nagoya-u.ac.jp.
  • Department of Thoracic Surgery, Kyoto University Hospital, 54 Shogoin-Kawahara-cho, Sakyo-ku, 606-8507, Kyoto, Japan.
  • Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan.
  • Department of Thoracic Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, 466-8550, Nagoya, Japan.

Zitieren

APA

Kayawake, H., Mineura, K., Sakanoue, I., Sumitomo, R., Nishikawa, S., Tanaka, S., Tsuji, K., Nakajima, D., Menju, T., & Chen-Yoshikawa, T. F. (2026). Clinicopathological and prognostic analysis of anaplastic lymphoma kinase-rearranged non-small cell lung cancer. General Thoracic and Cardiovascular Surgery. https://doi.org/10.1007/s11748-026-02424-2

Vancouver

Kayawake H, Mineura K, Sakanoue I, Sumitomo R, Nishikawa S, Tanaka S, et al. Clinicopathological and prognostic analysis of anaplastic lymphoma kinase-rearranged non-small cell lung cancer. General Thoracic and Cardiovascular Surgery. 2026. doi:10.1007/s11748-026-02424-2

BibTeX
@article{Kayawake2026,
  author = {Kayawake, Hidenao and Mineura, Katsutaka and Sakanoue, Ichiro and Sumitomo, Ryota and Nishikawa, Shigeto and Tanaka, Satona and Tsuji, Kentaro and Nakajima, Daisuke and Menju, Toshi and Chen-Yoshikawa, Toyofumi Fengshi},
  title = {Clinicopathological and prognostic analysis of anaplastic lymphoma kinase-rearranged non-small cell lung cancer},
  journal = {General Thoracic and Cardiovascular Surgery},
  year = {2026},
  doi = {10.1007/s11748-026-02424-2}
}
Kostenlos starten →